Needed Now


Book Description




American Biodefense


Book Description

Biological weapons have threatened U.S. national security since at least World War II. Historically, however, the U.S. military has neglected research, development, acquisition, and doctrine for biodefense. Following September 11 and the anthrax letters of 2001, the United States started spending billions of dollars per year on medical countermeasures and biological detection systems. But most of this funding now comes from the Department of Health and Human Services rather than the Department of Defense. Why has the U.S. military neglected biodefense and allowed civilian organizations to take the lead in defending the country against biological attacks? In American Biodefense, Frank L. Smith III addresses this puzzling and largely untold story about science, technology, and national security.Smith argues that organizational frames and stereotypes have caused both military neglect and the rise of civilian biodefense. In the armed services, influential ideas about kinetic warfare have undermined defense against biological warfare. The influence of these ideas on science and technology challenges the conventional wisdom that national security policy is driven by threats or bureaucratic interests. Given the ideas at work inside the U.S. military, Smith explains how the lessons learned from biodefense can help solve other important problems that range from radiation weapons to cyber attacks.













Needed Now: The "85% Quick Fix" in Bio-Defense


Book Description

The search for the best solution for bio-defense is proving to be an obstacle to finding the more immediate good solution. In the day when Americans have grown used to fast food, instant access to the Internet, and minimal United States casualties during war, many have come to expect a silver bullet solution for almost any problem. The military, like the rest of America, is often in quest for the 100% solution to its challenges. For example, the military, now awakened to the biological warfare/biological terrorism (BW/BT) threat, is in search of the perfect solution to the problem posed by biological weapons. The pursuit of the 100% solution often diverts efforts from potential quick (though incomplete) fixes for such tough problems that could provide valuable protection. Some new proposals are presented to provide an "85% Quick Fix", including implementation of a Bio-Threatcon level, building preparation, providing off the shelf 1/2 mask respirators and more. While the technical information in this paper needs further study, it is hoped this chapter will provoke discussion and stimulate the development of new ideas for immediate solutions (albeit partial solutions) rather than waiting on the 100% solution. In April 1990, two U.S. naval bases, Yokosuka and Yokohama, were attacked with botulinum toxin, and although they failed, the scenario could have turned out much different. A home-grown Japanese terrorist organization, Aum Shinrikyo, had amassed over a billion dollars in net worth and had developed a clandestine biological warfare program. This group became famous for its nerve agent attack in the Tokyo subways in March 1995 that killed 12 and injured 5,500. Fortunately, in 1990, technology and scientific know-how were not as accessible as they are today, and as a result, the Aum Shinrikyo cult had not perfected its program. To our knowledge, no U.S. forces became ill from this attack.










Vaccines for Biodefense and Emerging and Neglected Diseases


Book Description

The last 20 years has seen a rapid increase in infectious diseases, particularly those that are termed "emerging diseases" such as SARS, "neglected diseases" such as malaria and those that are deemed biothreats such as anthrax. It is well-recognized that the most effective modality for preventing infectious diseases is vaccination. This book provides researchers with a better understanding of what is currently known about these diseases, including whether there is a vaccine available or under development. It also informs readers of the key issues in development of a vaccine for each disease. - Provides a comprehensive treatise of the agents that are responsible for emerging and neglected diseases and those that can be used as biothreats - Includes the processes such as the vaccine development pathway, vaccine manufacturing and regulatory issues that are critical to the generation of these vaccines to the marketplace - Each chapter will include a map of the world showing where that particular disease is naturally found